SCHEMBL7140995

SCHEMBL7140995

O=C(O)CCN(C1(C(=O)NO)CC2OCOC2C1)S(=O)(=O)c1ccc(OCc2ccc(F)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MMP1 P03956 12/20 0.61
▸ MMP13 P45452 3/20 0.47
▸ ADAM17 P78536 6/20 0.44
▸ MMP2 P08253 1/20 0.44
▸ MMP9 P14780 1/20 0.44
▸ MMP14 P50281 1/20 0.44
▸ MMP8 P22894 3/20 0.42
▸ MMP3 P08254 1/20 0.42
▸ BCL2L1 Q07817 1/20 0.40
▸ MCL1 Q07820 1/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA7 P43166 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ ADAM33 Q9BZ11 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7135520 0.91 MMP1 (0.49) MMP1MMP13ADAM17MMP2MMP9
SCHEMBL7143794 0.91 MMP1 (0.73) MMP1MMP13MMP2MMP9MMP14
SCHEMBL7137273 0.90 MMP1 (0.55) MMP1MMP13ADAM17MMP2MMP9
SCHEMBL7141637 0.89 MMP1 (0.54) MMP1MMP13ADAM17MMP2MMP9
SCHEMBL7134771 0.89 MMP1 (0.53) MMP1MMP13ADAM17MMP2MMP9
SCHEMBL7140315 0.85 MMP1 (0.49) MMP1MMP13ADAM17MMP2MMP9
SCHEMBL7136841 0.83 MMP1 (0.50) MMP1MMP13MMP2MMP9MMP14
SCHEMBL7140254 0.83 MMP1 (0.43) MMP1MMP13ADAM17MMP2MMP9
SCHEMBL7330071 0.82 MMP1 (0.59) MMP1MMP13ADAM17MMP2MMP9
SCHEMBL7139241 0.80 MMP1 (0.57) MMP1MMP13ADAM17MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1041072-B1 Dioxocyclopentyl hydroxamic acids PFIZER PROD INC (US) 2003-07-16 — — EP disclosed
US-6214870-B1 ANTIARTHRITIC AGENTS; ANTICANCER AGENTS PFIZER INC 2001-04-10 — — US disclosed
EP-1041072-A1 Dioxocyclopentyl hydroxamic acids Pfizer Products Inc. (US) 2000-10-04 — — EP disclosed
Send feedback